Table 2 Lipid profile of the patients with RA between before and
after treatment in the two groups of 99Tc and
99Tc & GC
Lipid profile Group
|
99Tc
|
99Tc
|
99Tc
|
99Tc & GC
|
99Tc & GC
|
99Tc
& GC
|
|
Baseline |
Treated |
P values |
Baseline |
Treated |
P values |
CHO |
3.85 ± 0.84 |
3.90 ± 0.88 |
0.7465 |
4.33 ± 0.99 |
4.65 ±
1.18 |
0.0024 |
TG |
1.05 ± 0.57 |
1.22 ± 0.54 |
0.0441 |
0.89 ± 0.28 |
1.19 ± 0.39 |
< 0.0001 |
HDL-C |
1.05 ± 0.27 |
1.11 ± 0.23 |
0.1083 |
1.06 ± 0.21 |
1.32
± 0.32 |
< 0.0001 |
LDL-C |
1.93 ± 0.56 |
1.96 ± 0.61 |
0.9782 |
2.66 ± 0.93 |
2.68
± 0.98 |
0.7414 |
Apo A1 |
1.22 ± 0.24 |
1.30 ± 0.24 |
0.0179 |
1.08 ±
0.26 |
1.30 ± 0.32 |
< 0.0001 |
Apo B |
0.74 ± 0.18 |
0.73 ± 0.19 |
0.1993 |
0.87 ± 0.25 |
0.89
± 0.22 |
0.8376 |
Atherogenic Index |
4.11 ± 2.36 |
3.57 ± 0.64 |
0.0856 |
4.13 ±
0.87 |
3.56 ± 0.64 |
< 0.0001 |
Ratio of Apo B/Apo A1 |
0.65 ± 0.21 |
0.58 ± 0.18 |
0.0036 |
0.84 ± 0.31 |
0.69 ± 0.20 |
0.0001 |